Health ❯ Healthcare ❯ Chronic Diseases

Diabetes Management

Cardiovascular Risk Factors GLP-1 Receptor Agonists Blood Sugar Control Weight Loss Solutions Treatment Options Innovative Treatments Patient Care GLP-1 Agonists Therapeutic Innovations Insulin Administration Liraglutide Medication Risks Antidiabetic Medications Type 2 Diabetes Metabolic Surgery AI in Diagnostics

7 ARTICLES

last mo.

FDA Expands Afrezza Inhaled Insulin Approval to Children Ages 6 and Up

The authorization adds a needle-free, ultra‑rapid mealtime insulin for young patients with required lung‑function checks and a company affordability program.